Repligen
在场
高管
查看带有其 23 名主要高管的组织结构图
Repligen 搜索最多的简介
- Olivier Loeillot, President and Chief Executive Officer
- Carrie Eglinton Manner, Director
- Glenn Muir, Director
高管在Repligen变化
- Olivier Loeillot 曾任 President and Chief Commercial Officer, 将于 20249月1 升职为 President and Chief Executive Officer (新闻发布的2024六月14号).
创建提醒
跟踪 Repligen 的高管变动
健康
Repligen 拥有 1,982 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、UnitedHealthcare (美国(美洲)) 和 Siemens Healthineers (德国)。
Popular M&A news in 健康
- Oura Health 刚刚宣布为 200 筹款数百万美元。 (公布2024十二月20号).
- Neuronetics 已收购 Greenbrook TMS (公布2024十二月10号).
- Cleerly 刚刚宣布为 106 筹款数百万美元。 (公布2024十二月9号).
健康 行业的其他推荐联系人
消息
Repligen 的最新新闻稿
- Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
- Repligen enters agreement to acquire metenova
- Repligen enters agreement to acquire metenova
- New Affinity Resin for COVID-19 Vaccine Purification
- Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines | Repligen
- Repligen CEO Tony Hunt Knows Why Success Takes Time | Investor's Business Daily
- Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions | Repligen
- Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application | SAMSUNG BIOLOGICS
- Press Releases | Repligen
- Purolite Selects Repligen's Market-Leading OPUS® Pre-Packed Columns
- View more press releases Close
关于 Repligen 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Olivier Loeillot 
